Literature DB >> 12899634

Kinetic analysis of the action of tissue transglutaminase on peptide and protein substrates.

April Case1, Ross L Stein.   

Abstract

Tissue transglutaminase (TGase) catalyzes transfer of gamma-acyl moieties of Gln residues in peptides or protein substrates to either water or amine nucleophiles through an acyl-enzyme intermediate formed from initial acyl-transfer to an active site Cys residue. Natural substrates for this enzyme include proteins (e.g., tau, alpha-synuclein, and huntingtin) whose TGase-promoted polymerization may be causative in neurodegenerative diseases. As part of a program to find inhibitors of TGase, we have undertaken kinetic and mechanistic studies of the enzyme from guinea pig (gpTGase) and humans (hTGase). Key findings of this study include: (i) gpTGase-catalyzed transamidation of Z-Gln-Gly by Gly-OMe proceeds essentially as described above but with the involvement of substrate inhibition by Gly-OMe. This phenomena, resulting from the binding of nucleophile to free enzyme, appears to be a common feature of TGase-catalyzed reactions. (ii) Solvent deuterium isotope effects for hydrolysis of Z-Gln-Gly by gpTGase are (D)(k(c)/K(m)) = 0.45 and (D)k(c) = 3.6. While the latter results from general catalysis of deacylation, the former originates purely from the reactant state, hydrogen fractionation factor of the active site thiol with no involvement of general catalysis of acylation. (iii) Studies of the transamidation of N,N-dimethylated casein by Gly-OMe and dansyl-cadaverine suggest a complex kinetic mechanism for both enzymes that reflects contributions from four reactions: Gln hydrolysis, intramolecular transpeptidation, intermolecular transpeptidation, and transamidation by added nucleophile.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12899634     DOI: 10.1021/bi030084z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries.

Authors:  Thung-S Lai; Yusha Liu; Tim Tucker; Kurt R Daniel; David C Sane; Eric Toone; James R Burke; Warren J Strittmatter; Charles S Greenberg
Journal:  Chem Biol       Date:  2008-09-22

2.  Application of a Fluorescence Anisotropy-Based Assay to Quantify Transglutaminase 2 Activity in Cell Lysates.

Authors:  Sandra Hauser; Paul Sommerfeld; Johanna Wodtke; Christoph Hauser; Paul Schlitterlau; Jens Pietzsch; Reik Löser; Markus Pietsch; Robert Wodtke
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

3.  Gamma-glutamyl hydrolase: kinetic characterization of isopeptide hydrolysis using fluorogenic substrates.

Authors:  Jessica P Alexander; Thomas J Ryan; David P Ballou; James K Coward
Journal:  Biochemistry       Date:  2008-01-03       Impact factor: 3.162

4.  Tissue transglutaminase acylation: Proposed role of conserved active site Tyr and Trp residues revealed by molecular modeling of peptide substrate binding.

Authors:  Roberto A Chica; Paul Gagnon; Jeffrey W Keillor; Joelle N Pelletier
Journal:  Protein Sci       Date:  2004-03-09       Impact factor: 6.725

Review 5.  Transglutaminase 2 inhibitors and their therapeutic role in disease states.

Authors:  Matthew Siegel; Chaitan Khosla
Journal:  Pharmacol Ther       Date:  2007-05-13       Impact factor: 12.310

6.  Transglutaminase induces protofibril-like amyloid beta-protein assemblies that are protease-resistant and inhibit long-term potentiation.

Authors:  Dean M Hartley; Chaohui Zhao; Austin C Speier; Gavitt A Woodard; Shaomin Li; Zongli Li; Thomas Walz
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

7.  Differential activation of extracellular signal-regulated kinase 1 and a related complex in neuronal nuclei.

Authors:  Joseph J Lundquist; Serena M Dudek
Journal:  Brain Cell Biol       Date:  2008-04-05

8.  Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury.

Authors:  Matthew Siegel; Pavel Strnad; R Edward Watts; Kihang Choi; Bana Jabri; M Bishr Omary; Chaitan Khosla
Journal:  PLoS One       Date:  2008-03-26       Impact factor: 3.240

9.  Histaminylation of glutamine residues is a novel posttranslational modification implicated in G-protein signaling.

Authors:  Jakob Vowinckel; Silke Stahlberg; Nils Paulmann; Katharina Bluemlein; Maik Grohmann; Markus Ralser; Diego J Walther
Journal:  FEBS Lett       Date:  2012-09-26       Impact factor: 4.124

10.  Angiotensin I-converting enzyme inhibitor derived from cross-linked oyster protein.

Authors:  Cheng-Liang Xie; Jin-Soo Kim; Jong-Myung Ha; Se-Young Choung; Yeung-Joon Choi
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.